INmuneBIO Investors

INmuneBIO is a private equity firm based in La Jolla, California, founded in 2015 The firm specializes in investing in innovative biotechnology and pharmaceutical companies that are focused on developing novel therapies With a significant investment scale, INmuneBIO aims to drive advancements in immune-based treatments and enhance patient outcomes The firm leverages its expertise and strategic partnerships to identify and support promising opportunities in the healthcare sector

Employee Number: 11-50
Investors Number: 2
Funding Status: IPO
Headquarters: USA
Technology: Data-driven Technologies
Estimated Revenue: Less than $1M
Founded Date: 2015
Last Funding Type: Post-IPO Equity
Investor Type: Private Equity Firms
Total Funding: $48.2M
Industry: FemTech